Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
Venous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of risk assessment models and guidelines recommending primary thromboprophylaxis with low-molecular-we...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003595 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841543983511109632 |
---|---|
author | Nikola Vladic Cornelia Englisch Cihan Ay Ingrid Pabinger |
author_facet | Nikola Vladic Cornelia Englisch Cihan Ay Ingrid Pabinger |
author_sort | Nikola Vladic |
collection | DOAJ |
description | Venous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of risk assessment models and guidelines recommending primary thromboprophylaxis with low-molecular-weight heparins or direct oral anticoagulants, the application of these strategies is inconsistent. This review provides an overview of the current state-of-the-art venous thromboembolism risk assessment and thromboprophylaxis in ambulatory patients with cancer, focusing on existing risk assessment models and the latest guideline recommendations. Finally, it summarizes gaps in knowledge, discusses future directions, and highlights recent advances and state-of-the-art research presented at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. |
format | Article |
id | doaj-art-58a1843c5d9b4caa9e6672526a59c5c3 |
institution | Kabale University |
issn | 2475-0379 |
language | English |
publishDate | 2025-01-01 |
publisher | Elsevier |
record_format | Article |
series | Research and Practice in Thrombosis and Haemostasis |
spelling | doaj-art-58a1843c5d9b4caa9e6672526a59c5c32025-01-13T04:19:04ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792025-01-0191102664Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignanciesNikola Vladic0Cornelia Englisch1Cihan Ay2Ingrid Pabinger3Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaCorrespondence Ingrid Pabinger, Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AustriaVenous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of risk assessment models and guidelines recommending primary thromboprophylaxis with low-molecular-weight heparins or direct oral anticoagulants, the application of these strategies is inconsistent. This review provides an overview of the current state-of-the-art venous thromboembolism risk assessment and thromboprophylaxis in ambulatory patients with cancer, focusing on existing risk assessment models and the latest guideline recommendations. Finally, it summarizes gaps in knowledge, discusses future directions, and highlights recent advances and state-of-the-art research presented at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand.http://www.sciencedirect.com/science/article/pii/S2475037924003595cancercancer-associated thrombosisprimary prophylaxisrisk assessmentvenous thromboembolism |
spellingShingle | Nikola Vladic Cornelia Englisch Cihan Ay Ingrid Pabinger Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies Research and Practice in Thrombosis and Haemostasis cancer cancer-associated thrombosis primary prophylaxis risk assessment venous thromboembolism |
title | Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies |
title_full | Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies |
title_fullStr | Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies |
title_full_unstemmed | Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies |
title_short | Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies |
title_sort | risk assessment and prevention of cancer associated venous thromboembolism in ambulatory patients with solid malignancies |
topic | cancer cancer-associated thrombosis primary prophylaxis risk assessment venous thromboembolism |
url | http://www.sciencedirect.com/science/article/pii/S2475037924003595 |
work_keys_str_mv | AT nikolavladic riskassessmentandpreventionofcancerassociatedvenousthromboembolisminambulatorypatientswithsolidmalignancies AT corneliaenglisch riskassessmentandpreventionofcancerassociatedvenousthromboembolisminambulatorypatientswithsolidmalignancies AT cihanay riskassessmentandpreventionofcancerassociatedvenousthromboembolisminambulatorypatientswithsolidmalignancies AT ingridpabinger riskassessmentandpreventionofcancerassociatedvenousthromboembolisminambulatorypatientswithsolidmalignancies |